Related references
Note: Only part of the references are listed.Cigarette smoking and subtypes of bladder cancer
Xuejuan Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Age-Period-Cohort Models in Cancer Surveillance Research: Ready for Prime Time?
Philip S. Rosenberg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Ethnic Differences in Bladder Cancer Survival
David S. Yee et al.
UROLOGY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Genetic Susceptibility to Distinct Bladder Cancer Subphenotypes
Lin T. Guey et al.
EUROPEAN UROLOGY (2010)
Surveillance of Urothelial Carcinoma Stage and Grade Migration, 1993-2005 and Survival Trends, 1993-2000
Kevin A. David et al.
CANCER (2009)
A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy
Maria Elena Martinez et al.
GASTROENTEROLOGY (2009)
A Case-Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
Dalsu Baris et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
Marko Babjuk et al.
EUROPEAN UROLOGY (2008)
Management of low grade papillary bladder tumors
Harry W. Herr et al.
JOURNAL OF UROLOGY (2007)
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
Silvia Hernandez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Efficient interval estimation for age-adjusted cancer rates
Ram C. Tiwari et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2006)
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens
H Wallerand et al.
CARCINOGENESIS (2005)
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma
BSW van Rhijn et al.
CANCER RESEARCH (2004)
Evaluation and follow-up strategies for superficial bladder cancer
SM Donat
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG van Rhijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
BWG van Rhijn et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
K Sibley et al.
ONCOGENE (2001)
Share Paper
